Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

October 17, 2025

Study Completion Date

December 12, 2025

Conditions
Androgenetic AlopeciaFemale Pattern BaldnessMale Pattern Baldness
Interventions
DIETARY_SUPPLEMENT

DA-005

Oral Botanical Supplement HIF-1a inhibitor

DRUG

Topical minoxidil 5%

Topical minoxidil 5%

DRUG

DA-002

Topical Alpha 1 Agonist (GRAS)

DIETARY_SUPPLEMENT

Placebo Oral Tablet

Placebo Oral Tablet

OTHER

Placebo Topical Solution

Placebo Topical Solution

Sponsors
All Listed Sponsors
collaborator

Follea International Limited

INDUSTRY

collaborator

Daniel Alain, Inc.

UNKNOWN

lead

Applied Biology, Inc.

INDUSTRY